Framework of the Report
Main Conclusions
Key Findings
I. Overview of the Global Biopharmaceuticals Market in 2006
　　(I) Market Size and Characteristics
　　　　1. Market Size and Growth in 2006
　　　　2. Market Characteristics in 2006
　　　　3. Application of Advanced Technology
　　(II) Major Countries & Regions
　　　　1. U.S.A.
　　　　2. Europe
　　　　3. Denmark
　　　　4. Singapore
II. Overview of China's Biopharmaceutical Industry, 2005-2006
　　(I) Development Environment
　　　　1. Policy Environment
　　　　2. Investment Environment
　　　　3. Market Environment
　　　　4. Information Service Environment
　　(II) Present Situation
　　　　1. Industry Size
　　　　2. Molecular Biology
　　　　3. Pharmaceutical
　　　　4. Biological Equipment & Methods
　　　　5. Biological Evolution & Ecology
　　　　6. Plant Biopharmaceuticals
　　　　7. Animal Biopharmaceuticals
　　(III) Characteristics
　　　　1. New technology becomes main conventional method for the research and development of biopharmaceuticals
　　　　2. Cross-regional division of work become finer in the industry
　　　　3. The high-end R&D of new products dramatically boosts the industry's competitiveness
　　　　4. Outsourcing becomes biopharmaceutical enterprises' important development strategy
　　(IV) Existing Problems
　　　　1. Low Industrialization Degree, Long Productization Cycle
　　　　2. Poor Innovation, Lack of Key Technologies
　　　　3. Loose Market Regulation, Reduced Product Credibility
　　(V) Industry Segments
　　　　1. Genetic Engineering Drugs
　　　　2. Antibody Engineering Pharmaceutics
　　　　3. Blood Products
　　　　4. Vaccine
　　　　5. Diagnosis Reagents
　　　　6. Biochips
　　　　7. Chemical Medicine
　　　　8. Traditional Chinese Medicine
III. Analysis of the Layout of China's Biopharmaceutical Industry
　　(I) Present Regional Industry Layout
　　　　1. Overall Layout
　　　　2. Northeast
　　　　3. North China
　　　　4. East China
　　　　5. Southwest
　　　　6. Northwest
　　(II) Characteristics of Regional Industry Layout
　　　　1. Enterprises in the northeast and southwest focus on productization, and those in the central regions are dedicated to research and development
　　　　2. Foreign-oriented enterprises and foreign-invested enterprises are densely distributed in the coastal areas; enterprises in the hinterland are largely oriented toward the domestic market
　　(III) Development Trend of Regional Industry Layout
　　　　1. Cross-regional division of work become finer in the industry
　　　　2. HR-oriented regions and application-oriented regions strength cooperation
　　　　3. There is a notable trend of competition and cooperation between enterprises across regions
IV. Analysis of the Attractiveness of Chinese Development Zones to the Biopharmaceutical Industry in 2006
　　(I) Key Elements of the Attractiveness of the Development Zones
　　　　1. Industry Clusters
　　　　2. Generic Technology Platform
　　　　3. Policy Environment
　　　　4. Basic Services
　　　　5. Investment & Financing Environment
　　(II) Major Development Zones' Strategies
　　　　1. Beijing Zhongguancun Bio-Medicine Garden
　　　　2. Tianjin Economic-technological Development Area
　　　　3....
V. Development Trend of the Biopharmaceutical Industry in Chinese Development Zones, 2007-2009
　　(I) Policy Factors
　　(II) Economic Factors
　　(III) Service Factors
　　(IV) Technology Platform
　　(V) Investment & Financing
VI. Assessment of the Attractiveness of the Biopharmaceutical Industry in Chinese Development Zones, 2007-2009
　　(I) Index System
　　(II) Assessment of Attractiveness
　　　　1. Overall Ranking
　　　　2. Ranking by Elements
VII. Recommendations from Our.
　　(I) Strategic Recommendations
　　(II) Investment Recommendations


List of Tables
　　Market Size of China's Biopharmaceutical Industry, 2005-2006
　　Market Size of the Biopharmaceutical Industry in Chinese Development Zones in 2006
　　Market Size of the Biopharmaceuticals R&D Industry in Chinese Development Zones in 2006
　　Market Size of the Biopharmaceuticals Manufacturing Industry in Chinese Development Zones in 2006
　　Layout of the Biopharmaceutical Industry in Chinese Development Zones in 2006
　　...

List of Figures
　　Market Size of the Global Biopharmaceutical Industry, 2006-2007
　　Development of China's Biopharmaceutical Industry, 2006-2007
　　Development of the Biopharmaceutical Industry in the Development Zones, 2006-2007
　　
　　Size of the Segments of the Biopharmaceutical Industry in the Development Zones, 2006-2007
　　Development Trend of the Attractiveness of the Segments of the Biopharmaceutical Industry in the Development Zones, 2006-2007
　　
　　...